Practical implication
Regulatory intelligence teams must update workflows to exclude clove oil as an anesthetic for fish and ensure compliance with the guidance, including awareness of approved alternatives.
The FDA issued Guidance Document CVM GFI #150 which outlines significant concerns regarding the use of clove oil as an anesthetic for fish, stating that it has not been approved for such use and may pose safety risks.
What changed: Immediate implementation of guidance prohibiting the use of clove oil, isoeugenol, and methyleugenol as anesthetics in fish, referencing that these products are not approved new animal drugs.
Why it matters: This guidance addresses potential human food safety and animal food safety risks, highlighting carcinogenic components of clove oil. It delineates the approved alternatives for fish anesthesia, which are critical for maintaining food safety standards.
Practical implication: Regulatory intelligence teams must update workflows to exclude clove oil as an anesthetic for fish and ensure compliance with the guidance, including awareness of approved alternatives.
View original source
- Source: FDA - FDA Guidance Documents
- Published at source: 2026-08-25T13:16:00.000Z
- Discovered by monitor: 2026-08-25T23:20:17.411Z
Published from the regulator source ingestion pipeline after PV impact triage.
